(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 2. rho3 acts independently of slit. (A-D) Slit protein
levels are not changed in rho3 mutants. An anti-Slit antibody (in
green; red is the tracheal lumen, mAb2A12) detects similar levels of Slit in
early (C) and late (D) rho3 stage 16 embryos when compared with wild
type (A,B), even in the vicinity of branches that cross the midline in the
mutant (D, arrows). A-D are ventral views, anterior towards the left. Scale
bar in B: 20 µm. (E-G) A ventral view of late stage 16 embryos stained for
the tracheal lumen (by mAb2A12) reveals GB pathfinding defects in
slit mutants (F) and slit, rho3 double mutants (G) when
compared with wild type (E, anterior is towards the left). (H) Quantification
of the midline cross phenotype shows that the effect of the two mutations is
additive.